Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Journal of the American College of Cardiology
- Vol. 13 (3), 538-544
- https://doi.org/10.1016/0735-1097(89)90589-5
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Comparison of diltiazem and nifedipine alone and in combination in patients with coronary artery spasmJournal of the American College of Cardiology, 1987
- Effects of oral diltiazem in paroxysmal supraventricular tachycardiaThe American Journal of Cardiology, 1983
- Short- and long-term efficacy of high-dose oral diltiazem for angina due to coronary artery disease: a placebo-controlled, randomized, double-blind crossover study.Circulation, 1983
- Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.Circulation, 1983
- Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardiaThe American Journal of Cardiology, 1982
- Efficacy of diltiazem in angina on effort: A multicenter trialThe American Journal of Cardiology, 1982
- Multiclinic controlled trial of diltiazem for Prinzmetal's anginaAmerican Journal Of Medicine, 1982
- Effect of diltiazem in patients with variant angina: A randomized double-blind trialAmerican Heart Journal, 1981
- Comparative effects of three calcium antagonists, diltiazem, verapamil and nifedipine, on the sinoatrial and atrioventricular nodes. Experimental and clinical studies.Circulation, 1981
- Increased exercise tolerance after oral diltiazem, a calcium antagonist, in angina pectorisAmerican Heart Journal, 1981